Table 1 Clinical characteristics and outcome of the patients who underwent double stenting
Parameter | Number |
|---|---|
Age, median (range), years | 65 (41–86) |
Sex, male, n (%) | 33 (66) |
Distant metastasis at initical diagnosis, n (%) | 33 (66) |
Time from initial diagnosis to double stenting (IQR), mo | 5.9 (1.1–12.1) |
Timing of duodenal and biliary stenoses, n (%) | |
Simultaneous | 21 (42) |
Metachronous | 29 (58) |
Type of duodenal stenosis, n (%) | |
I | 20 (40) |
II | 21 (42) |
III | 9 (18) |
GOOSS score, mean ± SD | |
Before DuS | 0.9 ± 0.8 |
After DuS | 2.8 ± 0.4 |
Biliary drainage methods, n (%) | |
ERCP-BD | 35 (70) |
EUS-CDS | 12 (24) |
EUS-HGS | 3 (6) |
Type of biliary stent | |
PS | 11 (22) |
MS | 39 (78) |
Chemotherapy post double stenting, n (%) | 21 (42) |
Performance status at the double stenting, n (%) | |
0–1 | 28 (56) |
2–3 | 22 (44) |
Overall survital time (IQR), mo | 10.9 (6.0–18.4) |
Survival time from double stenting (IQR), mo | 2.4 (1.4–5.2) |